Top Markets
Coin of the day
NFL Biosciences S.A. NFL Biosciences S.A.

NFL Biosciences S.A.

ALNFL
Rank in Stocks #31528
Established in 2006 and headquartered in Castelnau-le-Lez, France, NFL... Established in 2006 and headquartered in Castelnau-le-Lez, France, NFL Biosciences S.A. is a biotechnology enterprise dedicated to pioneering natural remedies for addiction cessation, particularly for individuals seeking to quit smoking. Their most advanced therapeutic candidate, NFL-101, derived from tobacco, is currently progressing through Phase III clinical trials specifically designed to combat smoking addiction. Additionally, the company's research pipeline features NFL-201, an extract blending cannabis and tobacco, and NFL-301, a botanical formulation rooted in traditional Chinese medicine, both of which are undergoing preclinical assessment.
Share Price
$1.02
Market Cap
$12.96M
Change (1 day)
-0.92%
Change (1 year)
-43.11%
Country
FR
Trade NFL Biosciences S.A. (ALNFL)

Category

Earnings for NFL Biosciences S.A. (ALNFL)
Earnings in 2026 TTM: 0
According to NFL Biosciences S.A. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for NFL Biosciences S.A. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$5.27B -
US
$1.95B -
NL
$1.61B -
AU
- -
CH
- -
KR